Cervical Cancer Information Center

Cervical Cancer News

CIN Associated with Long-term Risk of Recurrence and Invasive Cervical Cancer (06/30/2009)
Women who have undergone treatment for cervical intraepithelial neoplasia (CIN) have a long-term increased risk of developing invasive carcinoma or a recurrence of CIN and, as such, need long-term surveillance, according to the results of a study published in the Journal of the National Cancer Institute.

Gardasil® Label Highlights Fainting Risk (06/12/2009)
Information about the risk of fainting has been added to the “Warnings and Precautions” section of the prescribing information for the HPV vaccine Gardasil®. As with any vaccine, Gardasil recipients should remain seated or lying down and be observed for 15 minutes following vaccination.

Sentinel Node Biopsy Is a Minimally-invasive, Effective Method for Determining Spread of Cervical Cancer (06/09/2009)
The majority of women with cervical cancer can safely undergo sentinel node biopsy instead of full pelvic lymph node dissection to determine the spread of their disease, thereby avoiding the complications associated with the more invasive procedure, according to the results of a study presented at the 2009 annual meeting of the American Society of Clinical Oncology in Orlando, Florida.

Gemzar® Added to Chemoradiation Improves Survival in Locally Advanced Cervical Cancer (06/08/2009)
The combination of Gemzar® (gemcitabine), Platinol® (cisplatin), and concurrent radiation significantly improves survival over single-agent Platinol and radiation in women with Stage IIB-IVA cervical cancer, according to the results of a study presented at the 2009 annual meeting of the American Society of Clinical Oncology in Orlando, Florida.

The National Breast and Cervical Cancer Early Detection Program (04/22/2009)
The National Breast and Cervical Cancer Early Detection Program (NBCCEDP)—a state and federal organization—is a nationwide, comprehensive public health program that helps uninsured and underinsured women gain access to screening services for the early detection of breast and cervical cancers.